Viewing Study NCT04097561


Ignite Creation Date: 2025-12-24 @ 12:22 PM
Ignite Modification Date: 2026-01-04 @ 2:21 PM
Study NCT ID: NCT04097561
Status: RECRUITING
Last Update Posted: 2025-08-14
First Post: 2019-09-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module